global
environment
chang
popul
growth
urban
make
viral
diseas
vd
one
major
caus
morbid
mortal
world
particular
emerg
reemerg
vd
pose
constant
threat
public
health
date
antivir
drug
approv
treat
human
immunodefici
viru
hiv
hepat
b
c
virus
hbv
hcv
cytomegaloviru
cmv
herp
simplex
viru
hsv
human
papilloma
viru
hpv
varicella
zoster
viru
vzv
vaccinia
viru
vacv
epsteinbarr
viru
ebv
respiratori
syncyti
viru
rsv
influenza
b
viru
iav
flubv
infect
import
vd
aciclovir
vzv
famiciclovir
vzv
valaciclovir
vzv
ebv
cmv
vidarabin
vzv
brivudin
vzv
foscarnet
cmv
lamivudin
hbv
peginterferon
hbv
hcv
peginterferon
hbv
hcv
ribavirin
rsv
hcv
tenofovir
disoproxil
hbv
trifluridin
vacv
target
one
vd
consid
urgent
need
develop
novel
antivir
includ
drug
emerg
reemerg
vd
apoptosi
cellular
antivir
process
exploit
develop
drug
process
pattern
recognit
receptor
prr
recogn
invad
virus
signal
protein
antiapoptot
bclxl
bclw
proapoptot
bax
bak
bad
protein
associ
dissoci
use
domain
start
cascad
event
lead
mitochondria
membran
permeabil
momp
cytochrom
c
releas
eventu
cell
death
antiapoptot
protein
may
repres
cellular
target
novel
antivir
moreov
commerci
avail
inhibitor
could
test
antivir
particular
antivir
properti
two
structur
distinct
class
anticanc
agent
could
investig
first
class
includ
deriv
wherea
second
class
includ
deriv
interestingli
current
clinic
trial
approv
treat
multipl
lymphoid
malign
howev
caus
revers
thrombocytopenia
anim
show
limit
replic
iav
flubv
middl
east
respiratori
syndrom
coronaviru
merscov
zika
viru
zikv
hbv
echoviru
induc
prematur
death
virusinfect
cell
concentr
toxic
noninfect
cell
show
induc
apoptosi
cell
transfect
viral
rna
plasmid
dna
mocktransfect
cell
suggest
compound
acceler
apoptosi
respons
foreign
nucleic
acid
also
demonstr
specif
induc
prematur
death
iavinfect
cell
limit
viral
replic
comparison
toxic
antivir
activ
side
effect
allow
us
select
antivir
lead
candid
thu
discov
potenti
solut
prevent
treatment
broadspectrum
vd
obatoclax
gemcitabin
purchas
selleck
chemic
houston
tx
usa
saliphenylhalamid
saliph
synthes
describ
previous
mm
solut
compound
prepar
dimethyl
sulfoxid
sigmaaldrich
st
loui
mo
usa
store
lyophil
lipopolysaccharid
lp
mgml
purchas
sigmaaldrich
st
loui
mo
usa
plasmid
pegfp
clontech
mountain
view
ca
usa
cat
hoechst
mm
solut
cat
atp
mm
solut
cat
thermo
fisher
scientif
waltham
usa
genom
rna
isol
influenza
strain
describ
previous
human
influenza
virus
grown
embryon
hen
egg
describ
previous
strain
propag
monolay
african
green
monkey
kidney
vero
adenocarcinom
human
alveolar
basal
epitheli
cell
respect
describ
earlier
vero
cell
use
prepar
stock
describ
previous
zikv
strain
cultur
vero
cell
describ
earlier
semliki
forest
viru
sfv
express
gener
vitro
transcript
cdna
electropor
mrna
babi
hamster
kidney
bhk
cell
previous
describ
hbv
particl
prepar
cultur
supernat
cell
describ
previous
merscov
propag
monolay
vero
cell
three
day
previous
describ
viru
stock
store
experi
virus
perform
complianc
guidelin
nation
author
use
appropri
biosafeti
laboratori
appropri
ethic
safeti
approv
cell
propag
human
retin
pigment
epitheli
rpe
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
uml
penicillinstreptomycin
penstrep
lglutamin
fetal
bovin
serum
fb
sodium
bicarbon
sigmaaldrich
viru
growth
medium
vgm
rpe
contain
bsa
mm
lglutamin
chloromethyl
ketonetrypsin
tpck
trypsin
sigmaaldrich
human
cell
grown
dmem
medium
supplement
uml
penstrep
mm
lglutamin
fb
vgm
contain
bsa
mm
lglutamin
chloromethyl
ketonetrypsin
tpck
trypsin
sigmaaldrich
dmem
grown
regular
dmem
supplement
fb
cell
maintain
dmem
supplement
fb
mm
lglutamin
uml
penicillin
streptomycin
previous
describ
vero
cell
grown
high
glucos
dmem
supplement
heatinactiv
fb
antibioticantimycot
solut
gibcolif
technolog
carlsbad
ca
usa
approxim
cell
seed
well
plate
cell
grown
h
appropri
cell
growth
medium
media
replac
vgm
contain
celltox
green
express
cytotox
reagent
ctxg
dilut
assay
well
promega
madison
wi
usa
compound
ad
cell
threefold
dilut
seven
differ
concentr
start
compound
ad
control
well
cell
mock
viru
infect
multipl
infect
moi
depend
viru
strain
induc
cytopath
effect
virusinfect
cell
typic
h
cell
imag
use
cytat
imag
reader
biotek
instrument
inc
winooski
vt
usa
brightfield
fluoresc
mode
nmem
fluoresc
measur
pherastar
fs
plate
reader
bmg
labtech
ortenberg
germani
media
remov
cell
celltiterglo
viabil
ctg
promega
madison
wi
usa
reagent
ad
per
well
luminesc
measur
pherastar
fs
plate
reader
raw
data
normal
calibr
standard
curv
curv
gener
use
purifi
human
genom
dna
atp
sigma
aldrich
curv
fit
use
logist
regress
analysi
dsdna
atp
calibr
curv
predict
coeffici
determin
rsquar
calcul
predict
residu
error
sum
squar
press
statist
allow
accur
estim
unknown
concentr
find
intersect
known
fluoresc
luminesc
measur
calibr
curv
doserespons
curv
fit
fourparamet
logist
function
equat
amin
amax
upper
lower
asymptot
minim
maxim
drug
effect
dose
produc
halfmaxim
effect
steep
slope
curv
f
x
amin
xm
use
composit
trapezoid
rule
estim
area
doserespons
curv
auc
commonli
use
metric
quantif
drug
respons
multipl
doselevel
allow
us
calcul
differenti
auc
dauc
two
doserespons
curv
exampl
plu
minu
viru
half
maxim
cytotox
concentr
half
maxim
effect
concentr
compound
determin
describ
previous
rel
effect
drug
defin
therapeut
select
index
si
cell
treat
remain
nontreat
infect
viru
h
supernat
collect
serial
dilut
pb
ad
mdck
cell
media
chang
cell
overlaid
plaqu
assay
media
cell
fix
viral
titer
calcul
titer
express
plaqueform
unit
pfu
tissu
cultur
infect
dose
fluorescenceform
unit
ffu
ml
valu
well
ratio
viru
titer
nontreat
compoundtr
cell
certain
concentr
calcul
iav
flubv
titer
use
plaqu
assay
mdck
cell
describ
earlier
titer
also
determin
plaqu
assay
cell
titer
determin
plaqu
titrat
vero
cell
presenc
human
immunoglobulin
g
describ
earlier
titer
plaqu
assay
cell
previous
describ
rpe
cell
cultur
confluenc
well
plate
transfect
ng
viral
genom
rna
use
lipofectamin
rnaimax
thermo
fisher
scientif
waltham
usa
ng
plasmid
dna
pegfp
use
lipofectamin
thermo
fisher
scientif
waltham
usa
one
thousand
cell
seed
per
well
plate
duplic
presenc
dilut
celltoxgreen
reagent
cell
infect
pfu
per
well
sfv
vector
plate
place
incucyt
zoom
live
microscop
essen
bioscienc
ann
arbor
mi
usa
set
imag
everi
min
movi
assembl
use
frame
still
imag
show
cell
everi
h
dynam
profil
perform
describ
previous
briefli
rpe
cell
plate
per
well
plate
corn
corn
ny
usa
h
cell
infect
iav
transfect
pegfp
plasmid
use
lipofectamin
follow
manufactur
instruct
three
hour
post
infect
one
hour
post
transfect
medium
replac
deriv
trehalos
experiment
buffer
dteb
dteb
contain
mm
trehalos
mm
kcl
edta
egta
bsa
mm
succin
mm
hepeskoh
digitonin
oligomycin
fluoresc
probe
sigma
peptid
bim
bid
puma
noxaa
bad
hrk
kj
rosspeterssen
ap
copenhagen
denmark
dmso
sigmaaldrich
fluoresc
signal
measur
nm
min
min
interv
use
cytat
imag
reader
biotek
instrument
inc
winooski
vt
usa
kinet
curv
plot
analyz
use
graphpad
graphpad
softwar
inc
la
jolla
ca
usa
mitochondri
depolar
delta
apoptot
prime
calcul
describ
metabolom
analysi
perform
describ
previous
briefli
label
intern
standard
mixtur
ad
sampl
cell
cultur
media
ml
solvent
acn
fa
ad
sampl
sampl
filter
sampl
analysi
perform
acquiti
uplcmsm
system
water
corpor
milford
usa
detect
system
xevo
tq
tandem
tripl
quadrupol
mass
spectromet
water
milford
usa
oper
posit
neg
polar
polar
switch
time
msec
electro
spray
ioniz
chosen
ioniz
mode
capillari
voltag
kv
polar
sourc
temperatur
desolv
temperatur
respect
maintain
constantli
throughout
experi
declust
potenti
collis
energi
optim
compound
multipl
reaction
monitor
mrm
acquisit
mode
select
quantif
metabolit
individu
span
time
given
individu
mrm
channel
dwell
time
calcul
automat
softwar
base
region
retent
time
window
number
mrm
function
also
depend
number
data
point
requir
form
peak
masslynx
softwar
version
water
corpor
milford
usa
use
data
acquisit
data
handl
instrument
control
data
process
done
use
targetlynx
softwar
water
corpor
milford
usa
metabolit
quantifi
calcul
curv
area
ratio
use
label
intern
standard
extern
calibr
curv
metabolom
data
transform
linear
model
empiricalbayesmoder
ttest
use
rbioconductor
softwar
packag
limma
analys
differ
metabolit
level
linear
model
fit
metabolit
benjaminihochberg
method
use
correct
multipl
test
signific
metabolit
determin
benjaminihochberg
fals
discoveri
rate
fdr
control
heatmap
gener
use
pheatmap
packag
base
log
transform
profil
data
metaboanalyst
version
mcgill
univers
ste
ann
de
bellevu
qc
canada
use
identifi
metabol
pathway
associ
viru
infect
affect
treatment
bclxl
factor
immunoprecipit
iavinfect
noninfect
rpe
cell
use
rabbit
antibclxl
antibodi
cell
signal
technolog
danver
usa
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
visual
coomassi
stain
entir
lane
specif
protein
band
cut
protein
ingel
digest
trypsin
result
peptid
analyz
use
liquid
mass
spectrometri
describ
previous
mass
spectrometri
data
search
use
inhous
mascot
proteinpilot
interfac
swissprot
databas
statist
signific
data
p
select
dynam
peptid
profil
reveal
bad
bim
bid
puma
noxa
enhanc
momp
iav
mockinfect
human
nonmalign
rpe
cell
repres
natur
target
iav
infect
figur
coimmunoprecipit
experi
use
antibodi
prosurviv
bclxl
follow
mass
spectrometri
show
sever
cellular
protein
includ
bad
bax
bak
uaca
pawr
flii
immt
well
viral
factor
ha
np
present
complex
figur
thu
experi
demonstr
proapoptot
protein
bad
bax
bak
prr
factor
involv
program
death
iavinfect
cell
shown
target
bclxl
alter
interact
proapoptot
bax
bad
bak
test
effect
viabil
rpe
cell
infect
iav
mock
carri
dose
respons
studi
readout
use
fluoresc
microscopi
visual
dead
green
live
blue
cell
fluoresc
microscopi
reveal
induc
prematur
death
iavinfect
cell
concentr
toxic
noninfect
cell
figur
valid
result
ctxg
ctg
assay
ctxg
assay
use
fluoresc
asymmetr
cyanin
dye
stain
dna
dead
cell
wherea
ctg
assay
quantifi
atp
indic
metabol
activ
live
cell
calcul
valu
differenti
area
doserespons
curv
mock
iavinfect
cell
assay
figur
c
e
high
valu
indic
effect
trigger
prematur
death
infect
cell
infect
cell
effect
observ
alreadi
h
post
infect
wherea
toxic
detect
least
h
mockinfect
cell
figur
moreov
effect
depend
dose
also
viral
load
figur
addit
evalu
effect
iav
replic
titter
virus
produc
cell
treat
nontreat
treatment
lower
iav
product
rpe
cell
indic
fold
chang
viru
titer
figur
e
obtain
similar
result
cell
figur
furthermor
activ
caspas
iavinfect
nontreat
mockinfect
rpe
cell
h
post
infect
figur
result
collect
suggest
induc
prematur
apoptosi
iavinfect
cell
lower
iav
product
importantli
induc
prematur
death
rpe
cell
infect
flubv
sfv
lower
viru
product
concentr
toxic
noninfect
cell
figur
obtain
similar
result
zikv
merscov
hbv
virus
use
differ
cell
line
figur
supplementari
movi
reaffirm
treatment
pancreat
cancer
cell
infect
sfv
low
moi
attenu
replic
spread
viru
cell
result
suggest
might
use
broadspectrum
antivir
hypothes
viral
foreign
rna
dna
could
trigger
apoptosi
test
transfect
rpe
cell
iav
rna
vrna
plasmid
dna
pdna
treat
transfect
cell
viral
rna
pdna
mocktransfect
cell
rapidli
die
treatment
figur
figur
b
import
note
cell
death
depend
amount
transfect
vrna
pdna
well
concentr
moreov
peptid
puma
bad
bid
induc
momp
pdnatransfect
cell
earli
h
post
transfect
contrast
cell
treat
cell
transfect
pdna
figur
f
expect
acceler
death
rpe
cell
treat
bacteri
lipopolysaccharid
lp
recogn
differ
prr
detect
intracellular
foreign
rna
dna
figur
next
experi
pretreat
rpe
cell
compound
inhibit
endocyt
uptak
obatoclax
saliph
transcript
replic
iav
gemcitabin
infect
iav
show
effect
cell
figur
result
confirm
intracellular
foreign
rnadna
replic
intermedi
trigger
apoptosi
acceler
process
order
provid
clue
mechan
apoptosi
investig
effect
analogu
viabil
death
iavinfect
mockinfect
rpe
cell
hpi
figur
addit
evalu
effect
compound
iav
replic
titer
virus
produc
cell
treat
increas
compound
concentr
calcul
si
valu
compound
observ
select
structur
similar
wherea
select
structur
similar
figur
figur
importantli
treatment
noninfect
rpe
cell
compound
alter
level
secret
adenin
adenosin
hypoxanthin
imp
amp
inosin
xanthosin
belong
atp
metabol
pathway
figur
altogeth
result
suggest
may
repres
antivir
lead
candid
gener
antivir
interfer
viru
replic
prevent
cell
death
achiev
inhibit
critic
step
viru
replic
cycl
either
direct
viru
target
target
host
cell
function
describ
altern
approach
small
molecul
limit
viru
replic
spread
induc
death
infect
cell
without
affect
noninfect
cell
show
induc
prematur
apoptosi
iavinfect
cell
physiolog
relev
concentr
also
facilit
apoptosi
cell
infect
flubv
sfv
zikv
merscov
hbv
transfect
iav
vrna
plasmid
dna
conclud
foreign
rnadna
trigger
apoptosi
cell
note
factor
iav
ha
np
protein
hsv
pk
gd
gj
may
acceler
deceler
apoptosi
disrupt
stabil
interact
cellular
protein
infect
cell
furthermor
demonstr
apoptosi
depend
load
viral
nucleic
acid
particular
treatment
induc
apoptosi
earli
stage
viral
infect
viral
load
high
late
stage
viral
infect
initi
concentr
viral
nucleic
acid
low
case
treatment
could
prematur
termin
viral
replic
mechanist
prr
recogn
intracellular
viral
rnadna
sent
signal
antiapoptot
protein
protein
releas
proapoptot
partner
initi
momp
atp
degrad
activ
result
cell
death
act
synergist
viral
rnadna
therebi
facilit
cell
death
figur
also
demonstr
specif
induc
prematur
death
iavinfect
cell
limit
viral
replic
importantli
effect
structur
similar
wherea
effect
structur
similar
unlik
caus
revers
thrombocytopenia
made
suitabl
antivir
lead
candid
structur
analogu
bound
bclxl
may
provid
idea
develop
compound
antivir
figur
bind
target
induc
major
conform
chang
backbon
movement
bclxl
disrupt
local
helic
structur
protein
structur
chang
seen
bind
compound
contain
chlorophenyl
moieti
compar
benzothiazol
moieti
moreov
addit
moieti
perturb
bclxl
structur
may
affect
bind
antiapoptot
partner
bad
bax
bak
perhap
protein
pawr
uaca
np
ha
possibl
high
affin
bclxl
protein
also
capac
alter
proteinprotein
interact
could
import
proapoptot
antivir
effect
sever
critic
issu
also
consid
develop
deriv
antivir
may
possess
broadspectrum
antivir
activ
vitro
virus
primari
patient
sampl
ex
vivo
antivir
efficaci
evalu
vivo
also
side
effect
includ
immuno
neuromodulatori
properti
studi
detail
particular
deriv
may
possess
advers
effect
acut
viru
infect
viral
dose
like
high
infect
larg
number
cell
induc
apoptosi
may
result
extens
tissu
damag
thu
deriv
must
evalu
prophylact
rather
therapeut
agent
virus
caus
acut
infect
explor
knowledg
virushost
interact
develop
pharmacolog
intervent
control
viral
infect
particular
understand
virusmedi
cell
death
highlight
potenti
use
apoptosisinduc
molecul
antivir
drug
studi
suggest
may
lead
proapoptot
compound
antivir
properti
prophylact
use
deriv
might
help
prevent
sever
viral
diseas
